Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Media Release
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298969/
http://dx.doi.org/10.1007/s40278-021-99295-y
_version_ 1783726167980769280
collection PubMed
description
format Online
Article
Text
id pubmed-8298969
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82989692021-07-23 Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome Reactions Weekly Media Release Springer International Publishing 2021-07-24 2021 /pmc/articles/PMC8298969/ http://dx.doi.org/10.1007/s40278-021-99295-y Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Media Release
Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome
title Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome
title_full Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome
title_fullStr Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome
title_full_unstemmed Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome
title_short Warning for Janssen COVID-19 vaccine: risk of Guillain-Barré syndrome
title_sort warning for janssen covid-19 vaccine: risk of guillain-barré syndrome
topic Media Release
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298969/
http://dx.doi.org/10.1007/s40278-021-99295-y

Ejemplares similares